Tier 4 — mechanistic
mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-β 1 -induced collagen biosynthesis
Science signaling
2019
12(582):eaav3048
Bibliography
- PubMed
- PMID 31113850
- PubMed Central
- PMC6584619
- Funding
- Indexed support: Biotechnology and Biological Research Council; National Institute for Health Research (NIHR); Wellcome Trust; Biotechnology and Biological Sciences Research Council; Medical Research Council; Fonds de la Recherche en Santé – Québec; GlaxoSmithKline. See the publication for grant and funder details.
- Competing interests
- The accessible abstract does not establish the authors' competing interests; absence of a statement is not evidence of no conflicts.
Study snapshot
| Design | Laboratory mechanistic study |
|---|---|
| Model | Fibroblast cell models of TGF-beta1-stimulated collagen production |
| Sample | Fibroblast and pathway-perturbation experiments; n varies by assay |
| Intervention | TGF-beta1 signaling with mTORC1/ATF4 and serine-glycine pathway manipulation |
| Duration | In-vitro mechanistic experiments |
| Endpoints | De novo glycine synthesis; Collagen production; mTORC1/ATF4 signaling |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified

